Vaccines Market Research Reports & Industry Analysis
Key issues in the global vaccine market today include product safety, supply shortages, the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems.
The topic of vaccine safety became prominent during the mid 1970’s with increases in lawsuits filed on behalf of those presumably injured by the diphtheria, pertussis, and tetanus (DPT) vaccine. To respond to public health concerns, Congress passed the National Childhood Vaccine Injury Act (NCVIA) in 1986, which in turn led to the creation of the National Vaccine Program Office (NVPO) within the Department of Health and Human Services (DHHS). NCVIA requires that all healthcare providers who administer vaccines containing diphtheria, tetanus, pertussis, polio, measles, mumps, rubella, hepatitis B, Haemophilus influenzae type b and varicella provide a Vaccine Information Statement (VIS) to the vaccine recipient, their parent or legal guardian prior to each dose. Each VIS contains a brief description of the disease as well as the risks and benefits of the vaccine. The NCVIA also mandated that all healthcare providers report certain adverse events that occur following vaccination. As a result, the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink Project (VSD) were established in 1990. VAERS provides a mechanism for the collection and analysis of adverse events associated with vaccines currently licensed in the U.S.; VSD involved forming partnerships with four large health maintenance organizations (HMOs) to continually monitor vaccine safety. The National Vaccine Injury Compensation Program, which was also created by NCVIA, compensates those individuals who have been injured by vaccines on a no-fault basis. On a global basis, the World Health Organization (WHO) is actively involved in ensuring the quality of vaccines.
Vaccines Industry Research & Market Reports
-
Anti-infective Vaccines Market Report 2023-2033
... underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increased Occurrence of New and Re-emerging Infectious Illnesses Driving ... Read More
-
RNA Therapeutics and RNA Vaccines Market, 2023-2035 (Forecasted Estimates)
... 2035 and is expected to grow at compounded annual growth rate (CAGR) of 50% during the forecast period (2026-2035). In the past few years, RNA based therapeutics have emerged as one of the key therapeutic ... Read More
-
Global Toxoid Vaccine Market - 2023-2030
... forecast period 2023-2030. Toxoid vaccines use toxoids (as antigens) to induce an immune response in protecting against diseases caused by toxins secreted by specific bacteria. Compared to other vaccines, toxoid vaccines are more stable and ... Read More
-
Clinical Trials Market by Phase (Phase I, II, III), Service Type (Laboratory, Analytical Testing, Patient Recruitment, Protocol Designing), Therapeutic Area (Oncology, Cardiology, Neurology), and Application (Vaccine, mAbs, CGT) - Global Forecast to 2028
... global clinical trials market is projected to reach USD 73.2 billion by 2028 from USD 48.2 billion in 2023, at a CAGR of 8.7% during the forecast period of 2023 to 2028. The growth of ... Read More
-
Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), Route of administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Type ( Human vaccine , Veterinary vaccine) - Global Forecast to 2028
... market size is projected to reach USD 1.2 billion by 2028 from USD 0.8 billion in 2023, at a CAGR of 6.9% during the forecast period. Factors such as as the rising prevalence of infectious ... Read More
-
North America Travel Vaccines Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... the market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028. Vaccines are defined as biological preparations that protect the human body against severe and potentially deadly diseases. ... Read More
-
Cancer Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... to reach US$ 12.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.61% during 2023-2028. Cancer is a malignant tumor caused by the uncontrollable growth of abnormal cells in the body. It can be ... Read More
-
Global Respiratory Syncytial Virus (RSV) Vaccine And Antibody Pipeline Market: Analysis By End User (Adult and Maternal & Pediatric), By Type (Vaccine & Antibody), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030
... Forecast up to 2030 RSV, or respiratory syncytial virus, is a common respiratory virus that causes mild, cold-like symptoms in both the upper and lower respiratory tracts. RSV can be harmful, especially in infants and ... Read More
-
Pharmaceutical Preparations Manufacturing in the UK - Industry Market Research Report
... important position in both the global pharmaceutical market and the UK economy. A large proportion of revenue is derived from export sales, but the value of exports has declined over the past five years. This ... Read More
-
Cancer Vaccines Market Report 2023-2033
... underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Adoption of Technology in Drug Development to Create Market ... Read More
-
Conjugate Vaccine Global Market Report 2023
... Adults 5) By End-User: Hospitals; Clinics; Homecare Settings Covering: Sanofi S.A; Pfizer Inc.; Merck & Co. Inc.; GlaxoSmithKline plc; Bharat Biotech International Limited Conjugate Vaccine Global Market Report 2023 from The Business Research Company provides ... Read More
-
Global Influenza Vaccines Market, Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Promising Influenza Vaccines in Clinical Development, Size, Share, Trends, Major Deals and Recent Developments - Forecast to 2030
... market is projected to reach US$ 10.9 Billion by 2030. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The Centers for Disease Control and Prevention (CDC) recommends routine seasonal influenza ... Read More
-
COVID-19 Vaccines Market Size, Trends and Analysis by Disease Overview, Epidemiology, Unmet Needs and Opportunities, Therapeutic Landscape, Pipeline Assessment, Clinical Trial Strategies and Forecast to 2026
... the COVID-19 market including disease overview, epidemiology, current treatment options, unmet needs and opportunities, R&D strategies, pipeline assessment, and market outlook. COVID-19 is a disease caused by the novel coronavirus, severe acute respiratory syndrome coronavirus ... Read More
-
Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2027, NAIC 325414
... benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.) to reach $72,305,485,209 by 2030. Vaccines, Skin Replacement Products and ... Read More
-
2023 Global: Meningococcal Vaccine Market - Innovative Markets Forecast (2029) report
... period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 to 2029 using ... Read More
-
2023 Global: Medical Refrigerators For Vaccine Storage Market - Innovative Markets Forecast (2029) report
... growth/decline and regional data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by ... Read More
-
India Pneumococcal Vaccine Market Assessment, By Type of Vaccine [Live attenuated vaccine, Inactivated vaccine and Subunit vaccine], By Adjuvant [Adjuvanted and Non-adjuvanted], By Route of Administration [Intramuscular, Subcutaneous, Intradermal, Others], By Age group [Infants, Children and Adult], By End-user [Hospitals, Specialty clinics, Homecare, Others], By Distribution Channel [Hospital, Retail Pharmacy, Online Pharmacy Government, Non-Governmental Organisations], By Region, By Opportunities and Forecast, FY2017-FY2031
... Children and Adult], By End-user [Hospitals, Specialty clinics, Homecare, Others], By Distribution Channel [Hospital, Retail Pharmacy, Online Pharmacy Government, Non-Governmental Organisations], By Region, By Opportunities and Forecast, FY2017-FY2031 India Pneumococcal Vaccine Market size was valued ... Read More
-
Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... Others), By Distribution Channel (Hospitals & Clinics, Governmental & Non-Governmental Organizations, Public & Private Alliances, Others), By Region, and By Competition Global human papillomavirus vaccine market is anticipated to observe impressive growth during the forecast ... Read More
-
Global Vaccine Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... has been substantial progress in the availability of critical public health vaccinations during the previous two decades. New vaccinations have been developed and distributed globally, saving many lives and preventing illness. However, a thorough examination ... Read More
-
Biological Product (except Diagnostic) Manufacturing - 2023 U.S. Market Research Report with Updated Recession Risk Forecasts
... assessments of the industry in the United States with over 100 data sets covering 2014-2027. This 63-page Kentley Insights report is packed with insightful data sets and forecasts to give you a comprehensive understanding of ... Read More
-
Global Influenza Vaccines Market - 2023-2030
... global influenza vaccines market is expected to exhibit a CAGR of 6.9% during the forecast period (2023-2030). Influenza (flu) vaccinations (flu shots) are vaccines that protect against the four influenza viruses that are expected to ... Read More
-
Japan Influenza Vaccine Market Assessment, By Type of Vaccine [Inactivated Influenza Vaccine, Live Attenuated Influenza Vaccine], By Type of Influenza [Seasonal and Pandemic], By Formulation [Trivalent, Quadrivalent], By Technology [Egg-based, Cell culture and Recombinant], By Age group [Paediatric and Adult], By Route of Administration [Intra-muscular injection, Nasal Spray], By Distribution Channel [Hospital, Retail Pharmacies, Government Suppliers and Others], By Region, By Opportunities and Forecast, FY2017-FY2031
... By Age group [Paediatric and Adult], By Route of Administration [Intra-muscular injection, Nasal Spray], By Distribution Channel [Hospital, Retail Pharmacies, Government Suppliers and Others], By Region, By Opportunities and Forecast, FY2017-FY2031 Japan Influenza Vaccine Market ... Read More
-
Vietnam Influenza Vaccine Market Assessment, By Vaccine Type [Inactivated Influenza Vaccine, Live Attenuated Influenza Vaccine], By Type of Influenza [Seasonal and Pandemic], By Formulation [Trivalent, Quadrivalent], By Technology [Egg-based, Cell culture and Recombinant], By Age group [Paediatric and Adult], By Route of Administration [Intra-Muscular Injection, Nasal Spray], By Distribution Channel [Hospital, Retail Pharmacies, Government Suppliers and Others], By Region, By Opportunities and Forecast, 2016-2030F
... Age group [Paediatric and Adult], By Route of Administration [Intra-Muscular Injection, Nasal Spray], By Distribution Channel [Hospital, Retail Pharmacies, Government Suppliers and Others], By Region, By Opportunities and Forecast, 2016-2030F Vietnam Influenza Vaccine market size ... Read More
-
Saudi Arabia Influenza Vaccine Market Assessment, By Vaccine Type [Inactivated Influenza Vaccine, Live Attenuated Influenza Vaccine], By Type of Influenza [Seasonal and Pandemic], By Formulation [Trivalent, Quadrivalent], By Technology [Egg-based, Cell culture and Recombinant], By Age group [Paediatric and Adult], By Route of Administration [Intra-Muscular Injection, Nasal Spray], By Distribution Channel [Hospital, Retail Pharmacies, Government Suppliers and Others], By Region, By Opportunities and Forecast, 2016-2030F
... By Age group [Paediatric and Adult], By Route of Administration [Intra-Muscular Injection, Nasal Spray], By Distribution Channel [Hospital, Retail Pharmacies, Government Suppliers and Others], By Region, By Opportunities and Forecast, 2016-2030F Saudi Arabia Influenza Vaccine ... Read More
-
Cell Culture Media Market by Type (Serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Defined, Classical, Specialty), Application (Biopharmaceutical (mAbs, Vaccine), Diagnostics, Tissue Engineering), End User (Pharma, Biotech) & Region - Global Forecast to 2028
... 2028 The global cell culture media market is projected to reach USD 13.0 billion by 2028 from USD 6.2 billion in 2023, at a CAGR of 16.0% during the forecast period. Rising demand for mabs ... Read More
Research Assistance
